Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

NCT01491763 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia Ph Positive

Interventions

DRUG: Imatinib

Sponsor

PETHEMA Foundation